韩国主要癌症发病率的区域差异,1999-2018年
Eun Hye Park1,2,3, Mee Joo Kang1,2, Kyu-Won Jung1,2
1Korea Central Cancer Registry, National Cancer Center, Goyang, Korea.
Epidemiology and health
|October 19, 2023
概括
在韩国,癌症发病率差异在市级上有很大差异. 近年来,女性的乳腺癌和男性的肝癌呈现出明显的集群,突出了需要本地化癌症控制政策的需要.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 空间分析 空间分析
背景情况:
- 癌症发病率呈现出地理差异.
- 了解区域差异对于有针对性的公共卫生干预至关重要.
- 以前的研究往往侧重于国家或省级,可能掩盖了当地差异.
研究的目的:
- 调查1999年至2018年的韩国市级癌症发病率差异.
- 在2014-2018年期间,在市级确定癌症集群热点.
- 为当地癌症政策和资源分配提供信息.
主要方法:
- 使用了韩国国家癌症发病率数据库.
- 计算了8种主要癌症类型的4个5年期间的性别和市区的年龄标准化发病率.
- 采用空间分析技术,包括全球莫兰的I,以检测癌症集群.
主要成果:
- 在城市层面,癌症发病率存在显著的区域差异,因癌症类型和性别而异.
- 对于男性来说,胃癌,结肠直肠癌,肺癌和肝癌的差异有所减少;最近,甲状腺癌和前列腺癌的差异有所减少.
- 在女性中,胃癌,结肠直肠癌,肺癌,肝癌和宫癌的差异下降;乳腺癌的差异稳步增加. 乳腺癌和肝癌集群分别在女性和男性中被确定.
结论:
- 市级分析显示,癌症发病率差异在国家层面并不明显.
- 已确定的癌症集群,特别是女性乳腺癌和男性肝癌,需要量身定制的本地干预措施.
- 研究结果为开发和实施有效的局部癌症控制策略提供了关键数据.
更多相关视频
07:50Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
222
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
296
相关概念视频
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Prevalence and Incidence
585
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
585
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
